Position in VRDN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$26,247,844
+$20,240,304 QoQ
Shares Held
1,428,843
+365.2% QoQ
Ownership
1.26%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#26
of 215 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,789,681,375 across 562 Biotechnology names. VRDN ranks #64 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in VRDN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,247,844 | 1,428,843 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $6,007,540 | 307,134 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $5,129,198 | 164,820 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $9,660,868 | 447,677 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $7,460,328 | 533,643 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,796,412 | 504,185 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $9,816,400 | 512,071 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,927,675 | 84,733 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,997,190 | 230,376 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,646,515 | 379,584 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $3,122,946 | 143,386 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,049,500 | 68,416 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $1,893,230 | 79,581 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,750,042 | 68,791 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $4,258,173 | 145,778 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $1,011,081 | 49,297 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $150 | 13 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $4,104 | 222 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $257 | 13 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $23,736 | 1,443 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $237 | 13 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $217 | 13 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||